EP3008062

Forlyfsafleiður af setnum tríasólópýridínum

  • Status:
    EP Einkaleyfi fallið úr gildi
  • EP appl. date:
    6.6.2014
  • EP published:
    5.4.2017
  • EP application number:
    14728949.0
  • Max expiry date:
    5.6.2034
  • Expiry date:
    5.6.2018
  • Title:
    PRODRUG DERIVATIVES OF SUBSTITUTED TRIAZOLOPYRIDINES

Timeline

Today
6.6.2014EP application
5.4.2017EP Publication
29.5.2017Translation submitted
15.6.2017Registration published
5.6.2018Expires

Owner

  • Name:
    Bayer Pharma Aktiengesellschaft
  • Address:
    Müllerstrasse 178, 13353, Berlin, DE

Inventor

  • Name:
    SCHULZE, Volker
  • Address:
    Hohen NeuendorfOT Bergfelde, DE
  • Name:
    LERCHEN, Hans-Georg
  • Address:
    Leverkusen, DE
  • Name:
    BIERER, Donald
  • Address:
    Haan, DE
  • Name:
    WENGNER, Antje Margret
  • Address:
    Berlin, DE
  • Name:
    SIEMEISTER, Gerhard
  • Address:
    Berlin, DE
  • Name:
    LIENAU, Philip
  • Address:
    Berlin, DE
  • Name:
    KRENZ, Ursula
  • Address:
    Leichlingen, DE
  • Name:
    KOSEMUND, Dirk
  • Address:
    Berlin, DE
  • Name:
    STÖCKIGT, Detlef
  • Address:
    Potsdam, DE
  • Name:
    BRÜNING, Michael
  • Address:
    Schildow, DE
  • Name:
    LÜCKING, Ulrich
  • Address:
    Berlin, DE
  • Name:
    TEREBESI, Ildikó
  • Address:
    Berlin, DE

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    13171508
  • Date:
    11.6.2013
  • Country:
    EP

Classification

  • Categories:
    C07D 471/04, A61K 31/437, A61P 35/00, A61K 38/00, C07F 9/6561, C07K 5/062, C07K 5/068

Annual fees

Number

Paid

Expires

Payer

Number: 4

Paid: 26.5.2017

Expires: 5.6.2018

Payer: Árnason Faktor

Upload documents